Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Intrathecal Hydromorphone in Chronic Pain
NCT01709747Phase 3Completed
- Sponsor
- Piramal
- Start
- Jun 2013
- Primary completion
- Feb 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of hydromorphone in chronic pain, sponsored by Piramal. Started Jun 2013; status: completed.
02
Drugs
hydromorphone
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT01709747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01709747.